Search Results - "Keyaerts M"

De waarde van drie fasen botscintigrafie voor diagnose van stress-geïnduceerde botpathologie.

Authors: Keyaerts, M. Buyse, L. Everaert, H.

Source: Sport & Geneeskunde. sep2007, Vol. 40 Issue 3, p20-31.

85TiP Phase II trial of HER2-PET/CT using 68Ga-anti-HER2 VHH1 for characterization of HER2 presence in brain metastases of breast cancer patients.

Authors: Keyaerts, M Xavier, C Everaert, H et al.

Source: Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.

Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer.

Authors: Lecocq, Q. Debie, P. Puttemans, J. et al.

Source: EJNMMI Research. 11/2/2021, Vol. 11 Issue 1, p1-13. 13p.

Preliminary in vivo evaluation of [131I]-2-iodo-D-phenylalanine as a potential radionuclide therapeutic agent in R1M-fluc rhabdomyosarcoma tumor-bearing NuNu mice using bioluminescent imaging.

Authors: Bauwens M Wimana L Keyaerts M et al.

Source: Cancer Biotherapy & Radiopharmaceuticals. Apr2010, Vol. 25 Issue 2, p225-231. 7p.

168P Characterization of the lung tumor microenvironment upon anti-PD-L1 therapy reveals an ambiguous role for TNF-α.

Authors: De Ridder, K. Locy, H. Piccioni, E. et al.

Source: Annals of Oncology. 2022 Supplement 2, Vol. 33, pS109-S109. 1p.

101P Predictors of 18F-fluorodeoxyglucose (F) positron-emission tomography (PET)-driven disease detection in patients (pts) with HER2[+] early breast cancer (EBC). A substudy of the PHERGain trial.

Authors: Llombart Cussac, A. Prat, A. Pérez-García, J.M. et al.

Source: Annals of Oncology. 2020 Supplement 2, Vol. 31, pS50-S50. 1p.

21PBaseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab.

Authors: Awada, G Özdemir, I Schwarze, J K et al.

Source: Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.

Immune modulation following α and β^- radionuclide therapy targeting fibroblast activation protein-α in a preclinical tumor model.

Authors: Ceuppens H De Ridder K Ertveldt T et al.

Source: Oncoimmunology [Oncoimmunology] 2025 Dec; Vol. 14 (1), pp. 2540054. Date of Electronic Publication: 2025 Aug 01.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

Efficient α and β^- radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour model.

Authors: Ceuppens H Pombo Antunes AR Navarro L et al.

Source: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2025 Jan; Vol. 52 (2), pp. 444-457. Date of Electronic Publication: 2024 Sep 06.

Publication Type: Journal Article

Journal Info: Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE

Clinicopathological and molecular predictors of [¹⁸F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial.

Authors: Llombart-Cussac A Prat A Pérez-García JM et al.

Source: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Jul; Vol. 51 (9), pp. 2733-2743. Date of Electronic Publication: 2024 Apr 08.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE

Optimal [¹⁸F]FDG PET/CT Cutoff for Pathologic Complete Response in HER2-Positive Early Breast Cancer Patients Treated with Neoadjuvant Trastuzumab and Pertuzumab in the PHERGain Trial.

Authors: Gebhart G Keyaerts M Guiot T et al.

Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 May 01; Vol. 65 (5), pp. 708-713. Date of Electronic Publication: 2024 May 01.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8⁺ T cell and iNKT cell activating mRNA vaccine.

Authors: Ertveldt T Meulewaeter S De Vlaeminck Y et al.

Source: Theranostics [Theranostics] 2023 Oct 09; Vol. 13 (15), pp. 5483-5500. Date of Electronic Publication: 2023 Oct 09 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE

Phase I Study of [⁶⁸Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I).

Authors: Gondry O Xavier C Raes L et al.

Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2023 Sep; Vol. 64 (9), pp. 1378-1384. Date of Electronic Publication: 2023 Jul 20.

Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

Targeted α-Therapy Using ²²⁵Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment.

Authors: Ertveldt T Krasniqi A Ceuppens H et al.

Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2023 May; Vol. 64 (5), pp. 751-758. Date of Electronic Publication: 2023 Apr 13.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

TNF-α-Secreting Lung Tumor-Infiltrated Monocytes Play a Pivotal Role During Anti-PD-L1 Immunotherapy.

Authors: De Ridder K Locy H Piccioni E et al.

Source: Frontiers in immunology [Front Immunol] 2022 Apr 14; Vol. 13, pp. 811867. Date of Electronic Publication: 2022 Apr 14 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade.

Authors: Lecocq Q Awad RM De Vlaeminck Y et al.

Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2021 Nov; Vol. 62 (11), pp. 1638-1644. Date of Electronic Publication: 2021 Mar 12.

Publication Type: Journal Article

Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med

Phase I Trial of ¹³¹I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients.

Authors: D'Huyvetter M Vos J Caveliers V et al.

Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2021 Aug 01; Vol. 62 (8), pp. 1097-1105. Date of Electronic Publication: 2020 Dec 04.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med

Generic semi-automated radiofluorination strategy for single domain antibodies: [¹⁸F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancer.

Authors: Dierick H Navarro L Ceuppens H et al.

Source: EJNMMI radiopharmacy and chemistry [EJNMMI Radiopharm Chem] 2024 Jul 24; Vol. 9 (1), pp. 54. Date of Electronic Publication: 2024 Jul 24.

Publication Type: Journal Article

Journal Info: Publisher: Springer Open Country of Publication: England NLM ID: 101714628 Publication Model: Electronic Cited Medium: Internet ISSN: 2365-421X (Electronic) Linking ISSN: 2365421X NLM ISO Abbreviation: EJNMMI Radiopharm Chem Subsets: PubMed not MEDLINE

Phase II Trial Assessing the Repeatability and Tumor Uptake of [⁶⁸Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast Carcinoma.

Authors: Gondry O Caveliers V Xavier C et al.

Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Feb 01; Vol. 65 (2), pp. 178-184. Date of Electronic Publication: 2024 Feb 01.

Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

The Presence of Anti-TPO Antibodies Increase the Likelihood of Post-I131 Hypothyroidism.

Authors: Quataert F Bravenboer B Keyaerts M et al.

Source: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme [Horm Metab Res] 2024 Feb; Vol. 56 (2), pp. 134-141. Date of Electronic Publication: 2023 Nov 06.

Publication Type: Journal Article

Journal Info: Publisher: Thieme Country of Publication: Germany NLM ID: 0177722 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-4286 (Electronic) Linking ISSN: 00185043 NLM ISO Abbreviation: Horm Metab Res Subsets: MEDLINE